PubRank

Piter J Bosma

Author PubWeight™ 16.18‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Prognostic significance of elevated cyclooxygenase 2 expression in patients with adenocarcinoma of the esophagus. Gastroenterology 2002 2.19
2 Induction of insolubility by herpes simplex virus VP22 precludes intercellular trafficking of N-terminal Apoptin-VP22 fusion proteins. J Mol Med (Berl) 2003 1.44
3 Anion exchanger 2 is essential for spermiogenesis in mice. Proc Natl Acad Sci U S A 2003 1.11
4 Insulin-like growth factor binding protein 5 enhances survival of LX2 human hepatic stellate cells. Fibrogenesis Tissue Repair 2010 0.92
5 Crigler-Najjar syndrome in The Netherlands: identification of four novel UGT1A1 alleles, genotype-phenotype correlation, and functional analysis of 10 missense mutants. Hum Mutat 2010 0.91
6 Ex-vivo evaluation of gene therapy vectors in human pancreatic (cancer) tissue slices. World J Gastroenterol 2009 0.90
7 Ephrin A2 receptor targeting does not increase adenoviral pancreatic cancer transduction in vivo. World J Gastroenterol 2009 0.84
8 Polyinosinic acid blocks adeno-associated virus macrophage endocytosis in vitro and enhances adeno-associated virus liver-directed gene therapy in vivo. Hum Gene Ther 2013 0.83
9 A genetically retargeted adenoviral vector enhances viral transduction in esophageal carcinoma cell lines and primary cultured esophageal resection specimens. Ann Surg 2003 0.82
10 A fiber modified adenovirus vector that targets to the EphrinA2 receptor reveals enhanced gene transfer to ex vivo pancreatic cancer. Int J Oncol 2010 0.82
11 Mycophenolate mofetil impairs transduction of single-stranded adeno-associated viral vectors. Hum Gene Ther 2011 0.82
12 Towards liver-directed gene therapy for Crigler-Najjar syndrome. Curr Gene Ther 2009 0.81
13 Adenoviral serotypes in gene therapy for esophageal carcinoma. J Surg Res 2007 0.79
14 Insulin-like growth factor 1 enhances bile-duct proliferation and fibrosis in Abcb4(-/-) mice. Biochim Biophys Acta 2013 0.78
15 Gene therapy for esophageal carcinoma: the use of an explant model to test adenoviral vectors ex vivo. Cancer Gene Ther 2004 0.78
16 Selection of tumour specific promoters for adenoviral gene therapy of cholangiocarcinoma. J Hepatol 2005 0.77
17 Gene therapy for barrett's esophagus: adenoviral gene transfer in different intestinal models. Cancer Gene Ther 2005 0.76
18 ATP8B1 and ATP11C: Two Lipid Flippases Important for Hepatocyte Function. Dig Dis 2015 0.75
19 Gene replacement therapy for genetic hepatocellular jaundice. Clin Rev Allergy Immunol 2015 0.75
20 The current state of cancer gene therapy and its application in esophageal carcinoma. Dig Surg 2005 0.75
21 Loss of heterozygosity and immunohistochemistry of adenocarcinomas of the esophagus and gastric cardia. Clin Cancer Res 2004 0.75
22 Overexpression of insulin like growth factor binding protein 5 reduces liver fibrosis in chronic cholangiopathy. Biochim Biophys Acta 2012 0.75
23 Ezetimibe: A biomarker for efficacy of liver directed UGT1A1 gene therapy for inherited hyperbilirubinemia. Biochim Biophys Acta 2012 0.75
24 Crigler-Najjar syndrome type 1 associated with combined 1070A-->G, Q357R and (TA)7 mutation in Kuwaiti Bedouin families indicate a founder effect in Arabs. J Clin Gastroenterol 2004 0.75